The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era
- PMID: 29662853
- PMCID: PMC5898991
- DOI: 10.5045/br.2018.53.1.3
The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era
Conflict of interest statement
Authors' Disclosures of Potential Conflicts of Interest: No potential conflicts of interest relevant to this article were reported.
Figures
References
-
- Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol. 2011;8:184–187. - PubMed
-
- Strebhardt K, Ullrich A. Paul Ehrlich's magic bullet concept: 100 years of progress. Nat Rev Cancer. 2008;8:473–480. - PubMed
-
- Schindler T, Bornmann W, Pellicena P, Miller WT, Clarkson B, Kuriyan J. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science. 2000;289:1938–1942. - PubMed
-
- O'Brien SG, Guilhot F, Larson RA, et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 2003;348:994–1004. - PubMed
-
- Innes AJ, Milojkovic D, Apperley JF. Allogeneic transplantation for CML in the TKI era: striking the right balance. Nat Rev Clin Oncol. 2016;13:79–91. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
